HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

This episode interviews Dr.

This episode discusses the 2023 update to the Beers Criteria, which identifies medications with risks outweighing benefits for older patients, covering its history, purpose, and clinical implications.

Two pharmacists discuss the newly released 2024 stress ulcer prophylaxis guidelines, examining the recommendations, underlying clinical trials, and potential disagreements with the guidelines.

This episode provides a brief review of the newly released 2026 AHA-ASA guidelines for acute ischemic stroke management, featuring an interview with clinical pharmacist Dr.

This episode discusses QT interval prolongation caused by medications, focusing on risk assessment, clinical implications, and management strategies for healthcare providers.

This episode discusses new developments in RSV prevention, including vaccines and monoclonal antibodies, featuring expert insights from Dr.

This episode breaks down the key changes and implications of the 2023 American Diabetes Association guidelines, discussing surprising updates in diabetes management.

This episode discusses potassium formulations and dosing strategies for treating hypokalemia, using a patient case to explore both outpatient and inpatient approaches.

This episode discusses the diagnosis and treatment of resistant hypertension in ambulatory care patients, including a new drug called aprazitantan (Trivio), through a clinical case example.

This episode discusses the new 2025 hypertension guidelines, focusing on key updates and their importance for healthcare providers managing this prevalent condition.

Two pharmacists discuss key updates from the newly published 2025 Acute Coronary Syndrome guidelines, focusing on pharmacotherapy aspects and clinical management.

This episode provides an in-depth educational review of statins, covering brand/generic names and mechanisms for healthcare students and providers.

This episode discusses the emergency reversal of anticoagulants like DOACs and warfarin in patients with major bleeding or needing urgent surgery, using a clinical case example.

This episode introduces HelixTalk's 2023 Drug Superlative Awards, where pharmacists humorously recognize notable drugs and drug classes based on their clinical characteristics and real-world use.

This episode explores digital health advancements, defining the concept, discussing its categories and examples, and examining how pharmacists can integrate it into practice and education.

This episode features an interview with Dr.

This episode discusses the recent FDA approval and ACIP/CDC evaluation of two new pneumococcal vaccines (PCV15 and PCV20), comparing them to existing vaccines and exploring their clinical implications.

This episode explores how genetic variations in the CYP2D6 enzyme affect drug metabolism, discussing implications for personalized medicine and clinical practice in pharmacy.

This episode explores the controversies surrounding compounded GLP-1 receptor agonists for weight loss, discussing their clinical and legal implications compared to FDA-approved versions.

This episode discusses the 2024 updates to the American Diabetes Association guidelines, focusing on their importance for healthcare providers in treating diabetes patients.

This episode discusses the concept of deprescribing pharmacotherapy, focusing on specific drug classes like benzodiazepines, antipsychotics, and antihyperglycemics, and the importance of following guidelines and monitoring patients during the process.

This episode provides an in-depth educational review of Angiotensin Receptor Blockers (ARBs), covering their pharmacology, indications, safety profiles, and clinical applications for healthcare students and providers.

This episode provides a concise review of high-yield pharmacy law topics for the MPJE exam, featuring expert insights on federal and state-specific regulations, with a focus on Illinois.

This episode provides an educational update on Paxlovid, covering drug interactions, pharmacist prescribing authority, side effects like 'Paxlovid mouth', and a brief drug review for healthcare professionals.

This episode features an interview with Dr.

This episode features pharmacists discussing hormonal contraceptives, including clinical insights and the new over-the-counter product Opil, with expert guests from women's health and academia.

This episode discusses the dual-acting GIP and GLP-1 receptor agonist terazepatide, covering its mechanism, clinical data, and potential role in diabetes treatment.

This episode explores how artificial intelligence and machine learning are transforming pharmacy practice, discussing current applications and future implications for pharmacists and patient care.

This episode provides a concise review of continuous glucose monitors (CGMs) for practicing pharmacists, covering device types, evidence-based guidelines, and the pharmacist's role in selection and education.

This episode explores how drug repository programs help patients afford expensive medications by redistributing unused prescriptions, focusing on state initiatives in Illinois and Wisconsin.

This episode provides an educational overview of peripheral arterial disease (PAD), covering its definition, staging, patient presentation, risk factors, treatment goals, and guideline-directed medication therapy recommendations.

This episode discusses Jernovix (Suzitrogene), a new non-opioid medication for acute pain management, exploring its evidence, safety, mechanism, and clinical applications through a patient case study.

This episode features an interview with Dr.

This episode continues a pharmacist-led educational discussion on hormonal contraceptives, focusing on non-oral dosage forms like the vaginal ring (NuvaRing) and its clinical details.

This episode examines the science, efficacy, and safety of medication abortion drugs Mifepristone and Misoprostol, while discussing current access issues and implications for pharmacists in the post-Roe v.

This episode analyzes the clinical data and mechanisms of Auvelity, a new combination drug containing dextromethorphan and bupropion for treating major depressive disorder, featuring insights from a psychiatric pharmacy specialist.

This episode discusses the significant updates to the 2023 GOLD Guidelines for COPD, featuring an interview with Dr.

This episode provides an educational deep dive into the drug Diltiazem, covering its pharmaceutics, medicinal chemistry, FDA Orange Book details, and various dosage forms for healthcare students and providers.

This episode analyzes a recent New England Journal of Medicine trial comparing hydrochlorothiazide and chlorthalidone for hypertension management, focusing on cardiovascular outcomes through a clinical case discussion.

This episode discusses updates to uncomplicated UTI diagnosis and treatment guidelines, highlighting outdated IDSA recommendations and newer resources from 2024.

This episode provides an in-depth review of 5-HT3 receptor antagonists for treating nausea and vomiting, covering pharmacology, indications, adverse effects, and comparisons between agents like ondansetron.

This episode provides a concise educational guide on the use of tacrolimus and mycophenolate in organ transplantation, featuring a clinical pharmacy expert discussing transplant topics during Donate Life month.

This episode provides an in-depth educational review of loop diuretic drugs, covering their pharmacology, common medications like furosemide, and clinical applications for conditions such as edema and heart failure.

This episode explains the FDA's Risk Evaluation and Mitigation Strategy (REMS) program, covering its definition, history, purpose, and impact on pharmacists and healthcare providers.

This episode compares Alteplase and Tenecteplase for treating acute ischemic stroke, discussing their effectiveness, safety, cost, and the evidence behind the shift to Tenecteplase in hospital systems.

This episode celebrates 150 episodes of HelixTalk by reflecting on its evolution from drug summaries to scientific updates, highlighting favorite episodes and thanking collaborators and listeners.

This episode discusses evidence-based pharmacologic treatments for opioid use disorder and the role of clinical pharmacists in patient care, featuring insights from a VA healthcare expert.

This episode of HelixTalk provides a comprehensive review of iron deficiency anemia, covering its definition, diagnosis through lab values, treatment options, and patient monitoring, introduced with a real-life clinical case to illustrate practical applications.

This episode of HelixTalk features an interview with Dr.

This episode of HelixTalk covers the key recommendations from the 2022 AHA/ACC/HFSA heart failure guidelines, focusing on clinical pearls and updates, including the integration of SGLT2 inhibitors.

Pharmacy faculty discuss updates in diabetes pharmacotherapy from the ADA's 2026 Standards of Care.

Pharmacy faculty discuss six newer antibiotics for treating multidrug-resistant gram-negative infections.

This episode discusses the impact of professional advocacy leading to pharmacists' ability to prescribe hormonal contraceptives in Illinois.

An educational podcast episode featuring a Q&A with Dr.

Pharmacy faculty discuss hypothyroidism, thyroid panel interpretation, and differences between thyroid medications for healthcare providers.

Pharmacy faculty provide an in-depth drug class review of NSAIDs, covering pharmacology, indications, and toxicity profiles.

Pharmacy faculty discuss updates in the 2019 Standards of Diabetes Care, focusing on diagnosis and treatment guidelines.

Pharmacy faculty discuss new evidence suggesting normal saline may be nephrotoxic and compare it to lactated ringers for IV fluid therapy.

Pharmacy faculty discuss the top 10 recommendations from the 2018 ACC AHA Lipid Guidelines, highlighting key updates and clinical implications.

Pharmacy faculty discuss the FDA's Unapproved Drugs Initiative and its impact on drug prices and shortages.